Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

NCT07125872 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed B-Cell Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD19 t-haNK- IV Administration

Sponsor

ImmunityBio, Inc.